Frederic Boned - Feb 8, 2024 Form 4 Insider Report for BALCHEM CORP (BCPC)

Role
SVP/GM, Human Nutri. & Health
Signature
/s/ Travis Larsen, Attorney in Fact for Frederic Boned
Stock symbol
BCPC
Transactions as of
Feb 8, 2024
Transactions value $
$0
Form type
4
Date filed
2/12/2024, 07:05 PM
Previous filing
Feb 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCPC Common Stock Award $0 +1.38K +35.01% $0.00 5.32K Feb 8, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCPC Stock Option Award $0 +4.5K $0.00 4.5K Feb 8, 2024 Common Stock 4.5K $143.43 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
F2 Includes acquisition of shares under the Balchem Corporation 401(k) plan.
F3 Options vest 20% Year 1; 40% Year 2: and 40% Year 3.